Burjeel announces acquisition of Medeor 24×7 Hospital in Dubai
This strategic decision is in line with the group's strategy to improve operational control and minimise fixed lease liabilities.
Situated near BurJuman in Bur Dubai, the Medeor 24x7 Hospital operated under a long-term lease earlier with a remaining commitment of Dh343m over the next 15 years.
The latest acquisition removes a substantial fixed rental liability.
The acquisition grants Burjeel full control over the hospital's operations, ensuring continuity and protecting the brand's equity. It also eliminates the risks associated with potential relocation, providing operational flexibility for future expansions and service diversification.
Its prime location and robust patient volumes support Burjeel's growth plans in Dubai and the Northern Emirates. These regions are identified as key areas for increasing presence due to strong demographic demand and service scalability.
Burjeel Holdings CEO John Sunil said: "By transitioning from leasehold to ownership in a key market, we reinforce our operational resilience and strengthen our platform for growth.
'Dubai, along with the Northern Emirates, remains a central focus of our expansion strategy, and securing full control of this asset enables us to deepen our presence and better serve these high-demand markets."
Medeor 24x7 Hospital, established in 2015, is a multi-specialty family hospital offering services including congenital malformation surgeries of the brain and spine, mother and childcare, cardiology, urology, pulmonology.
It is accredited by the Joint Commission International and features a laboratory accredited by the College of American Pathologists.
The move comes after Burjeel has inaugurated four new centres under its Alkalma mental health and well-being platform to broaden access to specialised mental healthcare.
"Burjeel announces acquisition of Medeor 24×7 Hospital in Dubai" was originally created and published by Hospital Management, a GlobalData owned brand.
The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
%3Amax_bytes(150000)%3Astrip_icc()%2FTAL-header-volcan-acatenango-guatemala-HIKEDVOLCANO0725-0e1578c9de574c85807380e89bbccd6d.jpg&w=3840&q=100)
Travel + Leisure
an hour ago
- Travel + Leisure
I Was Told I Might Never Walk Again—so I Hiked a Volcano in Guatemala
It was Christmas morning when I blinked awake to the mechanical beeping of a heart monitor. At first, I thought I was dreaming. My heart thumped loudly in my chest. I tried to roll over and orient myself, but my limbs were numb, and everything around me was a blur of pale light and quiet panic. The voices outside my hospital room faded in and out until one finally broke through the fog. A man rushed in—the one who changed everything. His face said it before his words did. 'It's lupus,' he said. I didn't know what that meant. I only knew it wasn't good. I was 22 and had just been accepted to William & Mary, a top public university in the U.S. I had been the picture of health. A hiker. A wild-hearted, barefoot-loving soul who spent her weekends chasing sunrises and meaningful conversations. I had always been a thinker—someone who mapped out dreams and imagined every possible 'what if' scenario life could throw at me. But even with all that imagination, nothing prepared me for the moment I stepped out of bed one morning and collapsed into my new reality. Tess while dealing with her diagnoses. Tess Moormans/Life Through A Lense Lupus is a chronic autoimmune disease. A body turned against itself. In a cruel twist of irony, after years of mentally picking myself apart, now my immune system was doing it for me—attacking perfectly healthy organs like they were intruders. It was a full-on war and I was losing. I was diagnosed with the worst class of it and told multiple times I might die. I almost did. The fatigue was relentless. The joint pain, unbearable. I received over nine blood transfusions just to keep me alive. The list of symptoms and restrictions, well, they were longer than my age. Tied with IVs to the hospital bed for more than a month, I remember the doctor rattling off day in and day out what I could no longer do: no more sun exposure, swimming, hugging friends, eating at restaurants, playing with animals, gardening, and walking in dirt. Even walking unassisted, they warned, might not be in the cards. I had a compromised immune system and was supposed to live in a sanitary bubble if I was to live at all. It was like someone had compiled a list of everything that made me me , then crossed it all out. I was a girl who ran and danced toward her dreams, tripping sometimes, but never stopping. Now, I was being told to sit still. But I've never been very good at doing what I'm told. And that's how I ended up 13,000 feet in the air, climbing Volcán Acatenango, one of Central America's highest peaks. The decision made no rational sense. Just months after being told I might never walk unassisted again, I was hiking into the sky on a path of volcanic ash and cloud-thin air. At the same time, it was one of the most logical decisions I ever made. Travel is so much more than movement and cool pictures in new places. It's how we reclaim pieces of ourselves. It's how we stretch beyond discomfort and fears and find out who other people are beyond our presumptions and who we are when no one else is around to define us. View of Volcán Acatenango seen through the clouds. Tess Moormans/Life Through A Lense I started the hike alongside a group of strangers—fellow adventurers whose names and stories I didn't know, but whose silent grit matched mine. There was something exhilarating about trekking next to people who knew nothing of my diagnosis, only my determination. After our bus dropped us off at the beginning of the trail, my heart sank. From the start, it was a slow, burning, upward climb. I am so glad I had no idea what lay ahead because I might have turned around right then and there. We passed through five microclimates in a day—humid jungle, alpine forest, wind-swept ridges, dry volcanic fields, and a cloud-pierced summit. Each shift was like stepping into another world entirely. As we climbed, Acatenango's landscape shifted beneath our feet. The farmlands gave way to dense forests. The air thinned. My legs burned. My lungs ached. I slowed. And slowed again. I was often last in line, stopping frequently to rest, my legs almost crumbling under me. And yet, I was still moving. Stray dogs are abundant in the farmland, and a beautiful chocolate shepherd shared the journey with us. I soon realized what I hadn't shared with anyone, he probably knew. Out of the 20 of us, he stuck by my side, stopping when I paused and walking together with me when I began again. The friendly stray dog who stuck by Tess's side; Hiking up Volcán Acatenango. Tess Moormans/Life Through A Lense When we reached base camp at 12,000 feet, I was shaking. My body throbbed. The trail narrowed and a dark windy fog quickly set in. I was surprised when our guide said our camp was just ahead because I could see nothing, not even a glowing light. It was icy cold. Where was Fuego, the elusive pillar of angry fire? We had been told there would be accommodations at the top. I didn't know whether to laugh or cry when I saw a stack of used mattresses, box springs, and shared sleeping bags. There was nothing sanitary about it, but it felt more healing than the hospital bed. We sipped hot chocolate around a flicker of a flame. I had come to see lava and was shivering around fading coals. But our guide was confident and told us we should wake up at 4 a.m. if we wanted to hike the remainder of the way to see Fuego up close and active. I had plenty of experience staying awake through the night from my weeks in the hospital. I had no idea how I would pull myself out of bed this time. Luckily, I didn't even have to set an alarm. At 2 a.m, I awoke to cold, wet slobber. The puppy that walked with me had curled up on my pillow. Having shared the trek, he wanted to share the warmth, too. I was more than a little annoyed and sat straight up, trying to drag him off my corner of the mattress. I kicked open the wooden door of our makeshift hut to shove him out and came face-to-face with Fuego. In the deep mist of the night, I had no idea our camp was clinging to a slab of cliff right in front of the summit. The earth growled and Acatenango's fiery twin erupted in the distance. It was bright and brilliant and alive and somehow almost outdone by the thousands of shimmering stars framing it. The deep fog that had suffocated everything was peeled back like a curtain and I realized all the beauty that had been hiding underneath. We rose for the summit. The final push. The hardest part. What seemed so close was a full three hours away still. A pillar of lava burst into the sky, glowing against the dusk. Around me, others gasped. Many reached for their phones and cameras. I stood in stunned silence. I wanted this image and memory etched in my mind before I tainted it with a camera lens. The eruption lit up the sky again and again throughout the night and early morning. I had barely slept. It was pitch black, and we were pushing through heavy sand and ash now. Two steps forward, a half step back. Mounds of crumbling dirt rose on either side, forming a slithering trail as we dipped down into the ravine and steadily rose up the other side. There was a moment, somewhere above the clouds, when I paused and turned around. The mountain where we camped, Acatenango, towered behind me, massive and ancient. Beneath its surface were deep, dark scars—grooves cut through the rock by old lava flows, now overgrown with stubborn green. I stood there, breathless from exertion and awe, already dripping sweat. I realized something that made me pause: The looming walls of dirt both engulfing me and forming my own path were the same. From the fog of sickness and the sting of IV needles, I was now coursing through the hazy vein of the mountain. The same burning force that had once destroyed this path had also shaped it—created it, even. And now, I traced it. My own body, too, bore scars—seen and unseen. Pain had carved through me, but it had also made this journey possible. I wasn't walking despite my pain. I was walking with it and becoming something through it. I was, by every definition, weak. But I was so strong. I was breathing hard—nearly wheezing—as the icy wind whipped against my face. My legs were leaden. My fingers were stiff and swollen. I stopped more than I moved. But I wasn't alone. Step by step, I made it to the top. There—at 13,045 feet—the sun rose above the world in every color imaginable—and some not even the most creative mind could fathom. Aerial view of Antigua, Guatemala. Tess Moormans/Life Through A Lense We stood in silence as clouds drifted below us and light spilled across the neighboring volcanic ridges—Agua Volcano to the left, Pacaya to the right. I was standing on Fuego in the shadow of Acatenango. Ironically, the name means 'Walled Place,' and here, I felt the walls placed around me come crumbling down. All I kept thinking was how everyone told me I couldn't—and how they weren't here to see this view. I reached my grimy, dirt-covered hand down to pet the dog in blatant defiance of my instructions not to be around or touch animals. I didn't ever want to descend. The way down was almost harder than the trail up. I was slipping, sliding, and tumbling, joy erupting inside me. Whether or not we realize it, we each travel every day—through grief, joy, and fire. We each have our own personal Fuegos and Acatenangos to face. Mine just happened to be a real one. When I returned from Guatemala, my lupus didn't vanish. But I proved that 'can't' is just a word. Acatenango didn't cure me, but it reminded me my journey didn't end in a hospital bed. It started there. It was Christmas morning when I blinked awake to the beeping of a heart monitor, my body a battlefield and my future a blur. But it was through the mist of the mountain where I really opened my eyes. They told me I'd never hike again. That I might never walk unassisted. That I would have to live a smaller life, if I lived at all. But they weren't there when the sky split open and fire danced across it. They didn't see me rise through ash and altitude, gasping and shaking, clinging to a mountain that had known its own share of eruptions. They didn't see the girl with IV scars, windburned cheeks, and dirt under her fingernails reach the summit with a dog by her side and a defiant heart in her chest. I didn't conquer the mountain—I bled into it. Walking on the wounds it once carried, I learned how to live with mine. And when Fuego erupted, lighting the sky like a pulse, I knew I would never be the same. Not because I reached the summit, but because I learned I could keep rising—even while breaking.
Forbes
an hour ago
- Forbes
Changes In Prior Approval Coming To Traditional Medicare, Medicare Advantage
There were two major announcements recently regarding prior approval of treatments and services for Medicare beneficiaries. In most medical insurance, many treatments won't be covered unless it is approved first by the insurer. It's been a source of controversy for some time. Original Medicare hasn't required prior authorization of treatments and services, with a few exceptions. For most care, providers and the patient agree on a treatment. After the treatment, paperwork for approval and payment is submitted to Medicare. Medicare recently announced a new model program that will test pre-approval. The voluntary model program will test pre-approval for some services and treatments, according to a recent announcement from the Center for Innovation of the Centers for Medicare and Medicaid Services. The model program is seeking medical providers to volunteer for the program from Jan. 1, 2026 through Dec. 31, 2031. The model will be restricted to New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington. Providers who volunteer and are accepted will agree to seek prior authorization for 17 items and services, including skin substitutes, deep brain stimulation for Parkinson's Disease, impotence treatment, and arthroscopy for knee osteoarthritis. A provider who volunteers for the program can choose not to seek prior approval for a case. There will be a post-treatment review of the case, and the provider will risk not being paid by Medicare for the treatment. CMS initiated the program and selected the services to be covered because of a series of reports showing waste, fraud or abuse in certain areas. For example, Medicare spent up to $5.8 billion in 2022 on unnecessary or inappropriate services that had no clinical benefit, according to the Medicare Payment Advisory Commission. Under the model, providers will submit the same information they currently submit for payment approval after a service is provided to a beneficiary. The difference is that under the model, the information will be submitted earlier and the provider will wait for approval before performing the services. CMS will select companies to receive and review the prior authorizations. It expects that they will use artificial intelligence and other tools in addition to medical professionals to review the submissions. The companies will be paid based on the extent to which they saved the government money by stopping unnecessary services. CMS said it will manage the program to avoid adverse impact on beneficiaries and providers. There was other news about pre-approval, this time involving Medicare Advantage plans. Pre-approval in Medicare Advantage plans has been controversial recently. There have been a number of recent reports and studies that found the authorization process was delaying treatment or causing patients to abandon treatment plans. Other reports indicated that a high percentage of treatments that initially were denied coverage eventually were approved if the patients or their providers appealed the than 50 major insurers who sponsor many types of insurance plans announced that they will voluntarily streamline prior authorization of treatments and services in all insurance markets, including Medicare Advantage plans. The insurers say they plan to have the new process in place by Jan. 1, 2027.
Yahoo
2 hours ago
- Yahoo
Labcorp Holdings Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
Labcorp Holdings (NYSE:LH) Second Quarter 2025 Results Key Financial Results Revenue: US$3.53b (up 9.5% from 2Q 2024). Net income: US$237.9m (up 16% from 2Q 2024). Profit margin: 6.7% (up from 6.4% in 2Q 2024). The increase in margin was driven by higher revenue. EPS: US$2.85 (up from US$2.44 in 2Q 2024). Trump has pledged to "unleash" American oil and gas and these 15 US stocks have developments that are poised to benefit. All figures shown in the chart above are for the trailing 12 month (TTM) period Labcorp Holdings Revenues Beat Expectations, EPS Falls Short Revenue exceeded analyst estimates by 1.2%. Earnings per share (EPS) missed analyst estimates by 12%. Looking ahead, revenue is forecast to grow 4.5% p.a. on average during the next 3 years, compared to a 6.3% growth forecast for the Healthcare industry in the US. Performance of the American Healthcare industry. The company's shares are up 8.7% from a week ago. Risk Analysis You should learn about the 2 warning signs we've spotted with Labcorp Holdings. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
